MicroPort Scientific Stock | Forecast, Price Target & Outlook 2026

MicroPort Scientific

SEHK:853

HK$ 9,93

+ HK$0,55 (5,86%)

9,93 HK$

+HK$0,55 (5,86%)

End-of-day quote: 03/27/2026

MicroPort Scientific Stock Value

Analysts currently give SEHK:853 a rating of Outperform.

Outperform

MicroPort Scientific Company Info

EPS Growth 5Y

-88,02%

Market Cap

HK$19,04 B

Long-Term Debt

HK$8,79 B

Annual earnings

03/28/2026

Dividend

HK$0,00

Dividend Yield

0,00%

Founded

1998

Industry

Health Care

Country

China

Website

MicroPort Scientific

ISIN Number

KYG608371046

Website

http://www.microport.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

HK$16,58

66.97%

Last Update: 03/28/2026

Analysts: 6

Highest Price Target HK$18,31

Average Price Target HK$16,58

Lowest Price Target HK$8,85

In the last five quarters, MicroPort Scientific’s Price Target has risen from HK$9,82 to HK$13,88 - a 41,34% increase. Six analysts predict that MicroPort Scientific’s share price will increase in the coming year, reaching HK$16,58. This would represent an increase of 66,97%.

Top growth stocks in the health care sector (5Y.)

What does MicroPort Scientific do?

MicroPort Scientific Corporation engages in the development and commercialization of innovative medical devices. The company is dedicated to improving the quality of life for patients worldwide through advanced medical technologies. The company core focus lies in the design, manufacturing, and marketing of various medical devices, particularly in the fields of cardiovascular, orthopedics, neurovascular, surgical robots, and cardiology. With a commitment to continuous innovation, the company endeavors to provide state-of-the-art solutions tailored to the needs of healthcare professionals and patients alike. An integral part of the company operations involves maintaining a robust research and development framework aimed at fostering cutting-edge advancements in medical technologies.

Business Segments

The company operates through multiple business segments, each specializing in distinct lines of medical technology. The principal segments include cardiovascular devices, orthopedic devices, and neurovascular devices, each contributing significantly to the overall performance and growth of the company. The cardiovascular devices segment encompasses products like coronary stents, balloon catheters, and cardiac devices aimed at treating cardiovascular diseases. Notably, the segment not only serves mature markets but also focuses on emerging markets where cardiovascular health solutions are in increasing demand.

In the orthopedic devices segment, the company offers innovative joint replacement solutions and trauma implants, catering to the growing global demand for orthopedic interventions. This segment has seen stable growth, primarily driven by the increasing prevalence of orthopedic ailments among aging populations.

The neurovascular devices segment focuses on technologies designed for the treatment of cerebrovascular diseases, such as aneurysms and stroke. This division is characterized by a commitment to innovating life-saving technologies that enhance clinical outcomes.

Additionally, the company’s surgical robotics segment is at the forefront of creating minimally invasive surgical solutions that integrate advanced robotics technology to assist surgeons. By employing cutting-edge techniques, this segment aims to revolutionize surgical procedures, thereby improving patient recovery times and surgical precision.

The company has effectively diversified its product offerings across its segments, enabling the company to cater to a wide range of medical conditions and patient needs. The overarching strategy incorporates comprehensive market analyses to identify gaps in healthcare delivery where The company can introduce impactful technological solutions. The collective growth of these business segments contributes to the comprehensive enhancement of patient care through innovative medical technologies.

Business Strategy

The company’s business strategy revolves around continuous innovation, strategic partnerships, and market expansion. The company is committed to advancing medical technology capabilities to provide innovative solutions that address unmet medical needs. This commitment to research and development is essential in maintaining a competitive edge within the rapidly evolving healthcare market.

Moreover, the company emphasizes the importance of expanding its international presence by entering emerging markets where demand for high-quality medical devices is on the rise. Through strategic marketing initiatives and establishing distribution networks, the company aims to build brand recognition and penetrate new geographical regions effectively.

Products and Services

The company offers a comprehensive range of products and services across its primary business segments. In the cardiovascular devices sector, the company specializes in coronary stents, balloon catheters, and various catheter-based technologies. The Firehawk® Rapamycin Target Eluting Coronary Stent System exemplifies the company’s commitment to innovation in providing sophisticated solutions for cardiovascular interventions.

The orthopedic segment encompasses joint replacement devices, trauma fixation systems, and innovative solutions for spine surgeries. These products are engineered to enhance the therapeutic outcomes of orthopedic interventions while ensuring safety and comfort for patients.

Neurovascular devices are another significant product line offered by the company, consisting of advanced stents, coils, and support devices specifically designed for treating conditions affecting the brain’s blood vessels. This specialized product range targets critical health issues such as aneurysms and stroke, reflecting the company’s dedication to addressing severe medical concerns.

The surgical robotics division showcases advanced robotic-assisted surgical systems that provide surgeons with enhanced precision during operations. The integration of robotics into surgical procedures signifies a revolution in minimally invasive surgery, providing better recovery outcomes for patients.

In addition to its product offerings, the company provides training and support services to healthcare professionals to ensure the effective application of its medical devices. The combination of innovative products and comprehensive support services distinguishes the company within the medical technology landscape.

Geographical Markets

The company operates in various geographical markets, with a focus on expanding its presence in both mature and emerging markets. The company’s international reach encompasses regions such as Europe, the Middle East, Africa (EMEA), South America, and Asia-Pacific. This global approach allows the company to leverage diverse market opportunities and cater to the specific medical needs of different populations.

In particular, the company has experienced significant growth in the EMEA and South American markets, driven by increasing healthcare demands and the necessity for high-quality medical devices. The engagement with local distributors and healthcare providers in these regions enhances the company’s ability to deliver effective solutions and build strong relationships within the healthcare community.

Seasonality

The company's business operations experience some level of seasonality, primarily influenced by healthcare spending cycles and market demands. Factors such as public health policies and insurance reimbursement processes can create fluctuations in product demand during specific periods of the year.

The company strategically anticipates these seasonal trends by aligning its production and marketing efforts to address peak purchase periods effectively. Maintaining an agile operational framework allows the company to optimize inventory management and ensure a continuous supply of its innovative medical devices.

Customers

The company serves a diverse range of customers, including healthcare providers, hospitals, and surgical centers across multiple geographical markets. The client base encompasses various categories, focusing on those entities that demand high-quality medical devices for surgical interventions.

The company has cultivated ongoing relationships with healthcare professionals, particularly in cardiology, orthopedics, and neurovascular fields. The company’s commitment to addressing the specific needs of different customer segments enhances its reputation as a reliable partner in healthcare.

Given the nature of its business segments, the company is equipped to serve a substantial number of customers, supported by a network of distributors and partners worldwide.

History

MicroPort Scientific Corporation was founded in 1998.

MicroPort Scientific Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Revenue by Segment:** - Cardiology: 45% - Orthopedics: 30% - Endovascular Products: 15% - Other Medical Devices: 10% **TOP 3 Markets:** - China: 50% - USA: 25% - Europe: 15% MicroPort Scientific Corporation generates the majority of its revenue from cardiology, followed by orthopedics and endova...

At which locations are the company’s products manufactured?

**Production Sites:** China, USA, France MicroPort Scientific Corporation mainly produces its products in China, where the company's headquarters are located. In addition, the company has production facilities in the USA and France to better serve its international markets. This geographical d...

What strategy does MicroPort Scientific pursue for future growth?

**Focus on International Expansion:** MicroPort Scientific Corporation has increasingly focused on tapping into new markets outside of China in recent years, particularly in the USA and Europe. **Investments in Research and Development:** The company has increased its spending on research and devel...

Which raw materials are imported and from which countries?

**Main raw materials:** Titanium, stainless steel, silicone, polyethylene **Import countries:** USA, Germany, Japan, China MicroPort Scientific Corporation, a leading company in the field of medical technology, imports a variety of raw materials needed for the production of their products. The key...

How strong is the company’s competitive advantage?

**Market Share:** 5% in the global medical technology market (2025, estimate) **R&D Investments:** 12% of revenue (2025) **Product Diversification:** Over 20 product lines in various medical fields MicroPort Scientific Corporation has established itself as a significant player in the global...

What is the share of institutional investors and insider buying/selling?

**Institutional Investor Share:** approximately 45% (estimated, based on historical data and typical industry values) **Insider Purchases/Sales:** No specific current data available (as of 2026) The institutional investor share at MicroPort Scientific Corporation typically falls within the range o...

What percentage market share does MicroPort Scientific have?

**Market share of MicroPort Scientific Corporation:** 8% (estimated, 2026) **Top competitors and their market shares:** 1. **Medtronic plc:** 15% 2. **Johnson & Johnson (MedTech):** 12% 3. **Boston Scientific Corporation:** 10% 4. **Abbott Laboratories (MedTech):** 9% 5. **MicroPort Scientific...

Is MicroPort Scientific stock currently a good investment?

**Revenue Growth:** 8.5% (2025) **R&D Expenses:** 12% of revenue (2025) **Market Share in Cardiology:** 15% (2025) In 2025, MicroPort Scientific Corporation recorded a revenue growth of 8.5%. This indicates a solid business development, especially in a competitive market environment. The compan...

Does MicroPort Scientific pay a dividend – and how reliable is the payout?

**Dividend yield:** 1.8% (2025) **Dividend history:** Continuous payout since 2018 MicroPort Scientific Corporation has paid a dividend in recent years, with the dividend yield standing at approximately 1.8% in 2025. The company has been consistently paying dividends since 2018, indicating a certai...

New support ticket

Explore

MicroPort Scientific Stock Value

MicroPort Scientific Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does MicroPort Scientific do?

MicroPort Scientific Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

MicroPort Scientific Stock Value

MicroPort Scientific Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does MicroPort Scientific do?

MicroPort Scientific Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.